Advertisement

Topics

Novo’s Victoza CV Benefit Claim Could Be Narrowed With FDA Panel Vote

17:43 EDT 20 Jun 2017 | SCRIP

US advisory committee strongly endorses cardiovascular risk reduction claim for the GLP-1 agonist but some panelists say new indication should...

      

Related Stories

 

Original Article: Novo’s Victoza CV Benefit Claim Could Be Narrowed With FDA Panel Vote

NEXT ARTICLE

More From BioPortfolio on "Novo’s Victoza CV Benefit Claim Could Be Narrowed With FDA Panel Vote"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...